← Open Payments lookup

MACKENZI HEATON: Open Payments

NPI 1811657034 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,221 in 30 payments from 14 companies in 2025. Trend: 2023 $4,047 · 2024 $2,344 · 2025 $1,221

Food & beverage: $1,221
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation10$181
Daiichi Sankyo Inc.2$152
Merck Sharp & Dohme LLC2$143
Gilead Sciences, Inc.2$138
Takeda Pharmaceuticals U.S.A., Inc.1$125
Janssen Biotech, Inc.1$125
AstraZeneca Pharmaceuticals LP2$121
PFIZER INC.4$101
ARRAY BIOPHARMA INC1$31
Stemline Therapeutics Inc.1$25

Products named: KISQALI, KEYTRUDA, ICLUSIG, RYBREVANT, IBRANCE, BRAFTOVI, ENHERTU, DATROWAY.

Industry payments across WA — which companies pay providers there.